Hans Hammers
@HHammersMD
Followers
4K
Following
3K
Media
237
Statuses
3K
Medical oncologist with focus on kidney cancer, immunotherapies and the tumor microenvironment. Views expressed are my own. #kidneycancer #immunotherapy
Dallas, TX
Joined February 2015
Truly excited for you and @MDAndersonNews. Well deserved!
Beyond thrilled to have matched @MDAndersonNews for Hematology/Oncology fellowship!!! Immensely grateful to my mentor @neerajaiims, @Huntsman_GU, and all the incredible mentors who made this possible: @umangtalking @TiansterZhang @littlejonesmd @HHammersMD @OncHahn #Match2025
0
1
11
With the cut in federal kidney cancer research funding consider supporting @KidneyCAN. Thank you ! 🙏 https://t.co/gC71ReLBbB
kidneycan.org
0
0
1
Thank you to everyone who joined us for our second annual Oncology Year in Review CME event on Saturday. We had a full lineup of UTSW experts discussing the latest breakthroughs in cancer care, research, and prevention. We hope to see you again in 2026.
1
1
7
QUITE lively 😁
Want to hear a lively debate on adjuvant RCC from #UromgiosLive 2025? @HHammersMD and @tompowles1 discuss and debate with the help of @montypal and @DrChoueiri
https://t.co/djgCKwNywq
0
0
2
A huge thanks to our Dear friends the @Uromigos for this kind invitation and honor. A Great 2⃣Days of GU Oncology with the BEST colleagues in the world. Grateful to our OncoAlert 🚨Faculty @tompowles1 & @brian_rini for the great hospitality!! Thanking #UromigosLive Ambassadors
0
11
22
Saving the best for last! Onto RCC session 🫘 Starting with an adjuvant session that promises to be particularly interesting after LITESPARK-022 was found to be positive! #Uromigoslive @OncoAlert @Uromigos
0
11
29
#uroamigoslive Excellent panel diving into the evolving role of adjuvant therapy in kidney cancer Focused on🔍 Patient selection,🧬 Biomarkers🎯 Optimizing post surgical outcomes @montypal @DrChoueiri @brian_rini @HHammersMD @tompowles1
0
5
11
Terrific panel #UromigosLive @tompowles1 asking Qs on adjuavnt Tx in RCC A rich conversation with differing views. @Uromigos @TresUramigas @uromigosjapan @DrChoueiri @HHammersMD @crisuarez08 @montypal
0
9
26
The best colleague who supports you when support is needed. @HHammersMD. Good to have @utswcancer representation at @Uromigos
1
2
12
There are lots of combination trials planned in #kidneycancer and a press release about positive data in the refractory space. What is the proper control arm for trials in IO- and VEGF-refractory RCC? @montypal @DrChoueiri @HHammersMD @OncoAlert
1
8
13
JUST IN: 2 Belzutifan (HIF2 inhibitor) phase III trials POSTIVE for Primary Endpoint in Renal Cell Carcinoma: LITEPSPAK022 (adjuvant) + LITESPARK011 (metastatic, post PD1). BIG NEWS for GU Oncology + Kidney Cancer patients! https://t.co/poOKpXP5nJ
https://t.co/wP9gu8ppLI
5
80
202
The #KCRS25 Abstract Supplement has been published in the October issue of The Oncologist! Explore the innovative #KidneyCancer research presented at this year’s Summit, from preclinical breakthroughs to clinical insights shaping patient care. Our sincere thanks to the KCRS
0
3
9
Beautiful work!! The link to hypercalcemia is particularly interesting and may help to enrich for patients benefitting from belzutifan! Congrats!
Excited to share our new preprint—the main project of my postdoc in the Kaelin lab! Blocking HIF2 doesn’t just slow tumors—it can reverse cachexia and hypercalcemia in kidney cancer. In the OSRC-2 model, HIF2 inhibition restored weight, preserved fat/muscle, and rescued survival.
1
3
14
Excited to join my outstanding colleagues at World Conference in GU cancers in Nashville TN. #WorldGU25 @ideolgyhealth Great work organizing @Daniel_J_George @CaPsurvivorship
4
7
25
Outstanding work! Practice changing! @tompowles1
This is huge. Congrats to @tompowles1 @BartsECMC & team who took this from a brilliant paper in @Nature in 2021 to a paradigm-shifting + P3 trial. @BladderCancerUS @IBCG_BladderCA
2
2
14
Great meeting!! Thank you everyone and in particular to our patient volunteers! Save the date for July 23/24 2026! #KCRS25 @kidneycan
3
2
19
Thank you @CJSTRAV3 @kidneycan
@CJSTRAV3 Inspirational words from a patient, advocate, and research collaborator at #KCRS25 Patients are not just participants they are partners in discovery and change. @kidneycan @IKCCorg @advocatekidneys @DrChoueiri @HHammersMD @OncoAlert @montypal @NazliDizman @yekeduz_emre
0
5
13
Look at some of the impact of DOD CDMRP funding. @BraunMDPhD is presenting the personalized vaccine in RCC published in @Nature. Please restore funding. It went from $50 Million to $0 Dollars. We have not solved cancer yet! @kidneycan #KCRS25
1
14
53
“Invest in PEOPLE.” Powerful reminder from @KimrynRathmell at #KCRS25 Because curing kidney cancer starts with empowering the next generation. @kidneycan @IKCCorg @advocatekidneys @DrChoueiri @HHammersMD @OncoAlert @montypal @NazliDizman @yekeduz_emre @AlbigesL @MikeSerzanMD
0
6
19
#KCRS2025 Great discussion on decentralized study design for rare histologies / non-clear cell RCC. We need to accelerate breakthroughs AND break down unnecessary regulatory barriers to allow Telehealth across state lines. NATIONAL MEDICAL LICENSES!! @kidneycan
1
3
16